Serum superoxide dismutase levels of beta thalassemia patients and effects of high dosage of intravenous desferrioxamine treatment on superoxide dismutase levels [1]

Mustafa Tekin, N. Akar, Y. Egin, S. Cin

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)371-374
Number of pages4
JournalPediatric Hematology and Oncology
Volume15
Issue number4
StatePublished - Jul 13 1998
Externally publishedYes

Fingerprint

Deferoxamine
beta-Thalassemia
Superoxide Dismutase
Serum
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Cancer Research
  • Management of Technology and Innovation

Cite this

@article{db419f5950434f21a4dd8f4eacaf6ec8,
title = "Serum superoxide dismutase levels of beta thalassemia patients and effects of high dosage of intravenous desferrioxamine treatment on superoxide dismutase levels [1]",
author = "Mustafa Tekin and N. Akar and Y. Egin and S. Cin",
year = "1998",
month = "7",
day = "13",
language = "English",
volume = "15",
pages = "371--374",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Serum superoxide dismutase levels of beta thalassemia patients and effects of high dosage of intravenous desferrioxamine treatment on superoxide dismutase levels [1]

AU - Tekin, Mustafa

AU - Akar, N.

AU - Egin, Y.

AU - Cin, S.

PY - 1998/7/13

Y1 - 1998/7/13

UR - http://www.scopus.com/inward/record.url?scp=0031807637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031807637&partnerID=8YFLogxK

M3 - Article

C2 - 9658440

AN - SCOPUS:0031807637

VL - 15

SP - 371

EP - 374

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 4

ER -